Multiple studies have been performed to examine clinical factors related to pCR rates in rectal cancer, including pretreatment carcinoembryonic antigen (CEA) level, circum-ferential extent, and distance from the anal verge (AV) among others [6]. Here, CEACAM5 is linked to rectal cancer.